Home » Stocks » IPIX

Innovation Pharmaceuticals Inc. (IPIX)

Stock Price: $0.1755 USD -0.0050 (-2.50%)
Updated Jan 13, 2021 3:59 PM EST - Market closed
Market Cap 85.21M
Revenue (ttm) 23,000
Net Income (ttm) -6.27M
Shares Out 337.49M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 13
Last Price $0.1755
Previous Close $0.1800
Change ($) -0.0050
Change (%) -2.50%
Day's Open 0.1725
Day's Range 0.1710 - 0.1837
Day's Volume 827,436
52-Week Range 0.053 - 0.65

News

Hide News
GlobeNewsWire - 1 day ago

Phase 2 clinical trial of Brilacidin for COVID-19 anticipated to commence this month Phase 2 clinical trial of Brilacidin for COVID-19 anticipated to commence this month

GlobeNewsWire - 1 month ago

WAKEFIELD, Mass., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces additional independent ...

About IPIX

Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. It develops Brilacidin, a lead drug compound for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company also develops Kevetrin, a lead anti-cancer compound for treating ovarian cancer. It has license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Ch... [Read more...]

Industry
Biotechnology
CEO
Leo Ehrlich
Employees
4
Stock Exchange
OTCMKTS
Ticker Symbol
IPIX
Full Company Profile

Financial Performance

Financial Statements